MU hardship exception application for eligible professionals due July 1

Laura Pedulli | | Health Exec | EMR/EHR

The Centers for Medicare & Medicaid Services (CMS) is reminding eligible professionals (EPs) that the application deadline for hardship exceptions is July 1. The agency also released a related tipsheet.

Medicare EPs can apply for a hardship exception to avoid the payment adjustments beginning on Jan. 1, 2015. Those who qualify for the exception must provide supporting documentation showing that they were unable to successfully demonstrate MU due to circumstances beyond their control, according to a CMS notice.

If granted, the exception is valid for one year.

The application for EPs is here and the application for EPs submitting multiple national provider identifiers is here.

View the related tip sheet here.

 

 

Laura Pedulli

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Radiology Business
Policies and regulations shaping radiology in 2025

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.